Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 196

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 196
---
 approval of transactions”
and (iii) approval of certain compensation-related matters require the approval described above under “—Board of directors
and officers—Compensation Committee.” Under our amended and restated articles of association to be in effect upon completion
of this offering, the alteration of the rights, privileges, preferences or obligations of any class of our shares requires a simple majority
of the class so affected (or such other percentage of the relevant class that may be set forth in the governing documents relevant to
such class), in addition to the ordinary majority vote of all classes of shares voting together as a single class at a shareholder meeting.
Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of
arrangement or reorganization, of the company pursuant to Section 350 of the Companies Law, which requires the approval of holders of
75% of the voting rights represented at the meeting and voting on the resolution, excluding abstentions.

Access to corporate records

Under the Companies Law,
all shareholders generally have the right to review minutes of our general meetings, our shareholder register, including with respect
to material shareholders, our articles of association, our financial statements, other documents as provided in the Companies Law, and
any document we are required by law to file publicly with the Companies Registrar or the Israel Securities Authority. Any shareholder
who specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction
with a related party which requires shareholder approval under the Companies Law. We may deny a request to review a document if we determine
that the request was not made in good faith, that the document contains a commercial secret or a patent or that the document’s
disclosure may otherwise impair our interests.

Acquisitions under Israeli law

Full tender offer

A person wishing to acquire
shares of a public Israeli company and who would as a result hold over 90% of the target company’s issued and outstanding share
capital or that of a certain class of shares is required by the Companies Law to make a tender offer to all of the company’s shareholders
or the shareholders who holds shares of the same class for the purchase of all of the issued and outstanding shares of the company or
of the same class, as applicable.

If the shareholders who do
not respond to or accept the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable
class of the shares, and more than half of the